BiochemistrybioRxivPreprint
Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concern
Payton A. B. Weidenbacher, Natalia Friedland, Mrinmoy Sanyal…·Peter S. Kim
This study evaluates the efficacy of a pan-sarbecovirus vaccine candidate against SARS-CoV-2 variants, finding that omitting strain-specific mutations improves cross-reactive neutralizing antibody responses.
6 citations